Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreThe Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreRAPID Pathway for Device Coverage
RAPID pathway could streamline Medicare coverage decisions for eligible breakthrough devices through earlier review alignment.
Read moreDetailed Summary of FY2027 IPPS Final Rule
CMS finalized FY 2027 hospital payment updates, including a 2.3% increase, new technology payments and AI-related policy changes.
Read more